Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial.
Muellejans B, Matthey T, Scholpp J, Schill M
Crit Care 2006, 10:R91
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
The incidence of sub-optimal sedation in the ICU: a systematic review
Jackson DL, Proudfoot CW, Cann KF, Walsh TS
Critical Care 2009, 13:R204 (16 December 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research    
Remifentanil discontinuation and subsequent intensive care unit-acquired infection: a cohort study
Nseir S, Hoel J, Grailles G, Soury-Lavergne A, Di Pompeo C, Mathieu D, Durocher A
Critical Care 2009, 13:R60 (21 April 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.


Review    
The place for short-acting opioids: special emphasis on remifentanil
Wilhelm W, Kreuer S
Critical Care 2008, 12(Suppl 3):S5 (14 May 2008)
 [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.


Research    
Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey
Martin J, Franck M, Sigel S, Weiss M, Spies C
Critical Care 2007, 11:R124 (6 December 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.